Fondation Institut Curie
Welcome,         Profile    Billing    Logout  
 14 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BRIANDET, Claire
BIOMEDE 2, NCT05476939: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Recruiting
3
409
Europe
Everolimus, VOTUBIA, AFINITOR, ONC201, Radiotherapy
Gustave Roussy, Cancer Campus, Grand Paris, Chimerix, Innovative Therapies For Children with Cancer Consortium, Ministry of Health, France
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
09/28
09/31
NEUROBLU 02, NCT03966651 / 2020-002996-36: A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

Recruiting
1
18
Europe
PRRT with 177Lu-DOTATATE
Institut Claudius Regaud, Advanced Accelerator Applications
Neuroblastoma
10/25
02/26
Doz, François
MS100070_0087, NCT05081180 / 2020-004397-22: Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

Active, not recruiting
1
17
Europe, Canada, RoW
Avelumab, Lenvatinib
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Central Nervous System Tumors
12/25
12/25
SCOOP, NCT04544995 / 2020-002359-39: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors

Terminated
1
47
Europe, RoW
Niraparib (Tablet for oral suspension), Dostarlimab, Niraparib (Tablet)
GlaxoSmithKline
Neoplasms
04/25
04/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BRIANDET, Claire
BIOMEDE 2, NCT05476939: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Recruiting
3
409
Europe
Everolimus, VOTUBIA, AFINITOR, ONC201, Radiotherapy
Gustave Roussy, Cancer Campus, Grand Paris, Chimerix, Innovative Therapies For Children with Cancer Consortium, Ministry of Health, France
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
09/28
09/31
NEUROBLU 02, NCT03966651 / 2020-002996-36: A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

Recruiting
1
18
Europe
PRRT with 177Lu-DOTATATE
Institut Claudius Regaud, Advanced Accelerator Applications
Neuroblastoma
10/25
02/26
Doz, François
MS100070_0087, NCT05081180 / 2020-004397-22: Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

Active, not recruiting
1
17
Europe, Canada, RoW
Avelumab, Lenvatinib
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Central Nervous System Tumors
12/25
12/25
SCOOP, NCT04544995 / 2020-002359-39: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors

Terminated
1
47
Europe, RoW
Niraparib (Tablet for oral suspension), Dostarlimab, Niraparib (Tablet)
GlaxoSmithKline
Neoplasms
04/25
04/25

Download Options